Patents by Inventor Riho KODAMA

Riho KODAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210009941
    Abstract: The present invention provides a composition for promoting cell proliferation containing polylysine in which at least one amino group is mono-substituted by dicarboxylic acid.
    Type: Application
    Filed: September 29, 2020
    Publication date: January 14, 2021
    Applicant: AJINOMOTO CO., INC.
    Inventors: Ryusuke HIRAMA, Riho KODAMA, Manabu KITAZAWA, Nao SUGIMOTO, Hiroki OZAWA
  • Publication number: 20190016763
    Abstract: A technique for efficiently culturing cells such as stem cells is provided. Cells such as stem cells are cultured using a cell culture vessel coated with a fibroin-like protein into which a cell adhesion sequence containing RGD (Arg-Gly-Asp) is inserted.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 17, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Manabu Kitazawa, Nao Sugimoto, Riho Kodama, Takeshi Nagahiko, Yoshihiro Ito, Kentaro Nakase, Yoshinori Takashima, Ayako Mine, Yoko Kuwabara, Uno Tagami, Masayuki Sugiki
  • Publication number: 20180230122
    Abstract: Compounds of formula (VI), which are useful as therapeutic drugs for diabetes, may be produced by reacting a compound of formula (II) with an acid halogenating agent to give an acid halide; reacting the acid halide with a compound of formula (IV) in the presence of a base, and crystallizing compound (V) or a salt thereof from the reaction system; and subjecting the compound of formula (V) to reductive deprotection in the presence of a metal catalyst, and crystallizing the compound of (VI) or a salt thereof from the reaction system:
    Type: Application
    Filed: April 16, 2018
    Publication date: August 16, 2018
    Applicant: EA PHARMA CO., LTD.
    Inventors: Tatsuhiro Yamada, Akinori Tatara, Ryuta Takashita, Riho Kodama, Kazutaka Ookuma
  • Publication number: 20160376249
    Abstract: Compounds of formula (VI), which are useful as therapeutic drugs for diabetes, may be produced by reacting a compound of formula (II) with an acid halogenating agent to give an acid halide; reacting the acid halide with a compound of formula (IV) in the presence of a base, and crystallizing compound (V) or a salt thereof from the reaction system; and subjecting the compound of formula (V) to reductive deprotection in the presence of a metal catalyst, and crystallizing the compound of (VI) or a salt thereof from the reaction system:
    Type: Application
    Filed: September 9, 2016
    Publication date: December 29, 2016
    Applicant: EA PHARMA CO., LTD.
    Inventors: Tatsuhiro YAMADA, Akinori TATARA, Ryuta TAKASHITA, Riho KODAMA, Kazutaka OOKUMA
  • Patent number: 9181202
    Abstract: Provided is a crystal of a salt of the compound represented by formula (I), which is excellent in its solubility in water. In particular, also provided is a crystal of hydrochloride, hydrobromate, sulfate, nitrate, p-toluenesulfonate or methanesulfonate of the compound represented by formula (I).
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: November 10, 2015
    Assignee: AJINOMOTO CO., INC.
    Inventors: Noriyasu Kataoka, Riho Kodama, Akinori Tatara
  • Patent number: 9102630
    Abstract: Provided is a crystal of a salt of the compound represented by formula (I), which is excellent in its solubility in water. In particular, also provided is a crystal of hydrochloride, hydrobromate, sulfate, nitrate, p-toluenesulfonate or methanesulfonate of the compound represented by formula (I).
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: August 11, 2015
    Assignee: AJINOMOTO CO., INC.
    Inventors: Noriyasu Kataoka, Riho Kodama, Akinori Tatara
  • Publication number: 20140206705
    Abstract: Provided is a crystal of a salt of the compound represented by formula (I), which is excellent in its solubility in water. In particular, also provided is a crystal of hydrochloride, hydrobromate, sulfate, nitrate, p-toluenesulfonate or methanesulfonate of the compound represented by formula (I).
    Type: Application
    Filed: March 12, 2014
    Publication date: July 24, 2014
    Applicant: AJINOMOTO CO., INC.
    Inventors: Noriyasu KATAOKA, Riho KODAMA, Akinori TATARA